Antacids Industry is Expected to Reach a Market Size of US$ 22 Billion by 2033

In 2023, the global antacids market is valued at US$ 14 billion and is expected to reach a market size of US$ 22 billion by 2033. The market is forecasted to increase at a CAGR of 4.6% from 2023 to 2033, according to Fact.MR.

Sales of antacids through online pharmacies are expected to increase faster at a CAGR of 5% over the forecast period due to the rising popularity of the online shopping culture.

High penetration of smartphones and improvements in telecom services are also driving antacid sales through online pharmacies.

Download Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=4328

Competitive Landscape

Leading companies are embracing tactics, including strategic alliances, quality control, acquisitions, product standards, supply chain management, and collaborations, to increase their geographic reach and improve their competitive position. Top antacid producers are focusing on new developments and introducing new products while following safety regulations to meet consumer demand.

For instance,

  • In 2020, Horizon Therapeutics PLC’s Vimovo delayed-release tablets were introduced by Lupin. The medication is used to lower the risk of stomach ulcers caused by naproxen.

Get Customization on this Report for Specific Research Solutions:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4328

Key Companies Profiled:

  • Bayer AG
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Novartis AG
  • Sanofi
  • Procter & Gamble
  • Dr. Reddy’s Laboratories Ltd.
  • Reckitt Benckiser Group plc
  • Sun Pharmaceuticals Ltd.
  • Takeda Pharmaceutical Company Limited

Key Segments Covered in Antacids Industry Research

  • By Drug Class :
    • Proton Pump Inhibitors
    • H2 Antagonists
    • Acid Neutralizers
  • By Formulation :
    • Tablets
    • Liquid
    • Powder
    • Others
  • By Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

For in-depth competitive analysis, Buy Now:

https://www.factmr.com/checkout/4328

Key Questions Covered in the Antacids Market Report:

  • What is the projected value of the Antacids factors Industry in 2023?
  • At what rate will the global Antacids factors market size grow until 2033?
  • Which are the factors hampering the growth of Antacids factors?
  • Which region is expected to lead in the global Antacids factors market by 2033?
  • Which are the factors driving the Antacids factors Industry during the forecast period?
  • What is the expected market value of the Antacids factors market during the forecast period?

Regional Analysis for Antacids Market:

  • APAC (Japan, China, South Korea, Australia, India, and the rest of APAC; the rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
  • North America (USA, Canada and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (Saudi Arabia, United Arab Emirates, South Africa)

What makes Fact.MR report stand out from others?

  • Fact.MR follows a six-point mechanism known as E.V.O.L.V.E. (Evaluate. Visualize. Overcome. Leverage. Verify. Eradicate.). The report is specially created to assess the COVID-19 impact on the Antacids industry. This mechanism focuses on almost all the factors in a definite manner to provide the best research report for the industry stakeholders.
  • Evaluate: A Fact.MR report evaluates every small aspect that can prove to be a growth generator for the Antacids industry, thus, making it different and special from other reports.
  • Visualize: The authors involved in the research activities visualized the post-COVID-19 era so that the key stakeholders of industry get an overview and helps them take certain steps to ensure continuous growth during the forecast period.
  • Overcome: The report scrutinizes on points that can prove to be an Achilles heel to the Antacids industry and assists to create strategies to overcome the obstacles that may hinder the growth of the Antacids industry.
  • Leverage: The Antacids industry can leverage certain aspects that can prove beneficial for the increase in growth rate. Fact.MR covers all the points on which the key stakeholders can leverage upon.
  • Verify: Research is done systematically to assure validation of all the aspects covered in the report. All the points are rechecked and verified thoroughly to avoid flaws and fake information.
  • Eradicate: Last but not the least, this aspect helps the key stakeholder eradicate all the obstacles that come between the growth rate and the Antacids industry.

About Us:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of industry research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Subscribe Newsletter for the Latest Updates

Matched content

Editor’s pick

Express Press Release Distribution